Skip to main content
SLBT logo

SL Science Holding Limited

SLBTNASDAQHealthcareBiotechnology

$1.53Today:- (-)1Y −85.02%

As of Oct 16, 2026 close

Market cap
$869.18M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.42$14.50
Volume (live)
-
Avg. volume (3M)
88.80K

SL Science Holding (SLBT) Financial Ratios

For fiscal 2024 (fiscal year ended Dec 31, 2024), SL Science Holding had return on equity of -25.6%, a current ratio of 84.61 (up from 19.09) and return on assets of -14.7%. A current ratio of 84.61 means current assets exceed current liabilities.

SL Science Holding Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023
Period endingDec 2024Dec 2023
Valuation Ratios
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-25.62%-
Return on Assets (ROA)-14.70%-
Return on Invested Capital (ROIC)-40.59%1.89%
Return on Capital Employed (ROCE)-20.40%2.40%
Leverage & Solvency Ratios
Debt/Equity-0.15
Debt/EBITDA-1.81
Liquidity Ratios
Current Ratio84.6119.09
Quick Ratio57.022.16
Efficiency Ratios
Asset Turnover0.66-
Inventory Turnover0.67-
Yield & Distribution Ratios

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2025. Data sources and methodology

Frequently Asked Questions About SL Science Holding Financial Ratios

What is SL Science Holding's return on equity?

SL Science Holding's return on equity (ROE) was -25.6% for fiscal 2024 (period ended Dec 31, 2024).

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition